Alison Yu

Alison Yu has extensive experience in translational cell therapy in the field of hematological oncology and autoimmune diseases. Alison has worked as a Senior Principal Scientist at Bristol Myers Squibb, overseeing late-stage cell therapy projects. Prior to this, Alison held positions at Boston Children's Hospital and Seattle Children's, where Alison managed clinical research and scientific studies related to stem cell transplantation and CAR T cell therapy. Alison has a PhD in Microbiology and Immunology, along with a background in Clinical Laboratory Science and Medical Technology.